AI assistant
Novonesis AS — Director's Dealing 2009
Feb 27, 2009
3377_rpt_2009-02-27_baa8f869-dc5e-4eea-af76-00e4ab0e0f85.pdf
Director's Dealing
Open in viewerOpens in your device viewer
TRADING BY MANAGEMENT IN NOVOZYMES A/S B SHARES
February 27, 2009
In accordance with Section 28a of the Danish Securities Trading Act, Novozymes reports the following transactions under ISIN DK0010272129, Novozymes B shares under the symbol NZYM B.
| Name | Relation/ Category of close relation |
Trading date | Character of the transaction |
No. of shares traded Buy (+) / Sell (-) |
Market value of shares traded (DKK) |
|---|---|---|---|---|---|
| Per Falholt | EVP & CSO | 26/2 2009 | Share options | + 3,995 - 3,995 |
591,260 1,773,780 |
Contact persons:
Press and media: Investor relations:
Johan Melchior Tel. (direct): +45 4446 0690 Tel. (mobile): +45 3077 0690
Paige Donnelly (USA) Tel. (direct): +1 919 494 3209 Tel. (mobile): +1 919 218 4501
Camilla Kinch Jensen Tel. (direct): +45 4446 0852 Tel. (mobile): +45 3077 0852
Tobias Bjørklund (USA) Tel. (direct): +1 919 494 3483 Tel. (mobile): +1 919 649 2565
Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources. Read more at www.novozymes.com.
Company announcement no. 6, 2009 Page 1 of 1 Novozymes A/S Investor Relations
Krogshøjvej 36 2880 Bagsværd Denmark
Telephone: +45 4446 0000 Fax: +45 4446 1002
Internet: www.novozymes.com CVR number: 10 00 71 27